After yesterday's closing bell,
warned that its third- and fourth-quarter earnings would be lower than expected, sparking a slew of analyst actions this morning.
downgraded the stock to neutral from attractive, while
Credit Suisse First Boston
cut its third-quarter EPS estimate to 45 cents from 60 cents, and
cut its 2000 EPS outlook to $2.27 from $2.60 and 2001 EPS outlook to $2.65 from $3.
Charles River Laboratories
: 12-month price target UP to $45 from $37 at Lehman.
: UP to $48 from $31 at Lehman.
: CUT from
Goldman Sachs' U.S. Recommended for Purchase List
: DOWN to market perform from buy at
Donaldson Lufkin & Jenrette
( NWAC): 2000 EPS estimate DOWN to $3 from $3.20 at DLJ.
: NEW neutral at
Salomon Smith Barney
: NEW outperform at Lehman.
CSFB started coverage on four clothing retailers: